The trademark application CAHtalyst was filed by Neurocrine Biosciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 25, 2020, and it was registered by office on October 8, 2020 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on November 26, 2020.
Goods And Services
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development services
Conducting clinical trials for pharmaceutical preparations
Conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
Providing research information to patients and practitioners as to the results of clinical trials
All of the foregoing excluding use in the field of ophthalmology.
The mark was filed in class 44 with Providing medical information and excluding medical information in the field of ophthalmology..